LOGIN 
Harnessing data to create innovative solutions
Enable strategic planning and adaptation to ensure success in the biotechnology market.
You’re faced with unique challenges:
Data Integration
Overcoming fragmented data silos to gain comprehensive insights is a significant challenge.
Regulation
Due to their complexity and potential risks, biopharmaceuticals are subject to rigorous regulatory scrutiny. Regulatory bodies like the FDA and EMA have specific pathways for approving these products to ensure their safety and efficacy.
Cost and Value
While biopharmaceuticals can be more expensive to produce and purchase compared to traditional drugs, their ability to treat previously untreatable conditions or provide better outcomes can justify the higher cost.
The GPI platform delivers insightful research for developers of Orphan Drugs. For example, organisations with new cancer drugs, or drugs used for additional indications can take advantage of emerging opportunities, via accurate pricing strategies and launch information. GPI experts can help you react quickly, stay ahead of competitors, and speed your product’s approval.
An assessment of the Orphan drugs landscape for pharma manufacturers 
How we help
GPI are experts in biotechnology data and insight, and can help you get to market successfully.
Market assessment
Access our data to understand patient population, product differentiation and the success factors that payers value.
Regulatory insight
Prepare for HTA approval processes and compliance standards knowing you have the right evidence to speed your path to market. Know the product characteristics that matter most to payers.
Cost and value
Biopharmaceuticals can be more expensive to produce and purchase compared to traditional drugs. Get the right market positioning using our value-based pricing models, in conjunction with our insight on indications. Help payers treat previously untreatable conditions or provide better outcomes and justify higher costs.
Reimbursement success
Overcome reimbursement challenges, especially in price-sensitive environments. Understand competitor pricing and build your target TPP with insights from our platform.
Expert guidance on hand
Access our team of experts to help navigate this complex landscape. Our data scientists have the experience to analyse relevant biopharma data, and our team of consultants can provide objective recommendations. We can help you build successful strategies.
GPI’s insight on the current state of cell and gene therapies (CGT)
Read the Blog